NASDAQ:CELZ Creative Medical Technology (CELZ) Stock Price, News & Analysis $3.63 +0.07 (+1.97%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$3.57▼$3.6350-Day Range$3.33▼$4.4752-Week Range$2.90▼$10.28Volume2,074 shsAverage Volume94,949 shsMarket Capitalization$4.90 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Creative Medical Technology alerts: Email Address Creative Medical Technology MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.16% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.97Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.29) to ($2.58) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.04 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Creative Medical Technology.Read more about Creative Medical Technology's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.16% of the float of Creative Medical Technology has been sold short.Short Interest Ratio / Days to CoverCreative Medical Technology has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Creative Medical Technology has recently decreased by 14.12%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCreative Medical Technology does not currently pay a dividend.Dividend GrowthCreative Medical Technology does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CELZ. Previous Next 2.8 News and Social Media Coverage News SentimentCreative Medical Technology has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Creative Medical Technology this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Creative Medical Technology insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.60% of the stock of Creative Medical Technology is held by insiders.Percentage Held by InstitutionsOnly 1.42% of the stock of Creative Medical Technology is held by institutions.Read more about Creative Medical Technology's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Creative Medical Technology are expected to grow in the coming year, from ($3.29) to ($2.58) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Creative Medical Technology is -0.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Creative Medical Technology is -0.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCreative Medical Technology has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Creative Medical Technology's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Creative Medical Technology Stock (NASDAQ:CELZ)Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.Read More CELZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CELZ Stock News HeadlinesJuly 24 at 9:00 AM | globenewswire.comCreative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine ProgramJuly 10, 2024 | globenewswire.comCreative Medical Technology Holdings Provides Corporate UpdateJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.June 24, 2024 | globenewswire.comCreative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human InsulinApril 24, 2024 | morningstar.comCreative Medical Technology Holdings Inc CELZMarch 24, 2024 | finance.yahoo.comCreative Medical Technology Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 18, 2024 | forbes.comMedical Practices And Branding In A Digital AgeMarch 18, 2024 | theglobeandmail.comCreative Medical Technology Skyrockets on Word of New Diabetes MedicationJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.March 7, 2024 | msn.comWhy Is Diabetes Focused Creative Medical Stock Surging On Thursday?March 7, 2024 | markets.businessinsider.comCreative Medical Announces FDA Authorization For Expanded Access For CELZ-201; Stock UpMarch 7, 2024 | marketwatch.comCreative Medical Shares Rise 37% After FDA Authorization for CELZ-201March 7, 2024 | msn.comCreative Medical stock rallies for second day on FDA updatesMarch 7, 2024 | finance.yahoo.comCreative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded AccessMarch 6, 2024 | morningstar.comCreative Medical Technology Holdings IncMarch 6, 2024 | markets.businessinsider.comCreative Medical Receives FDA Orphan Drug Designation For CELZ-101; Stock Up In Pre-marketMarch 6, 2024 | marketwatch.comCreative Medical Shares Rally Premarket on FDA Orphan DesignationMarch 6, 2024 | msn.comCreative Medical stock rallies 18% on FDA orphan drug designationSee More Headlines Receive CELZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/10/2024Today7/26/2024Next Earnings (Estimated)8/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:CELZ CUSIPN/A CIK1187953 Webwww.creativemedicaltechnology.com Phone(833) 336-7636FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.74) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,290,000.00 Net MarginsN/A Pretax Margin-58,633.34% Return on Equity-46.50% Return on Assets-44.93% Debt Debt-to-Equity RatioN/A Current Ratio23.54 Quick Ratio23.53 Sales & Book Value Annual Sales$10,000.00 Price / Sales490.05 Cash FlowN/A Price / Cash FlowN/A Book Value$7.48 per share Price / Book0.49Miscellaneous Outstanding Shares1,350,000Free Float1,299,000Market Cap$4.90 million OptionableNot Optionable Beta2.11 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Timothy Warbington (Age 62)Co-Founder, Chairman, President & CEO Comp: $429kMr. Donald Dickerson (Age 59)Senior VP, CFO & Director Comp: $390kKey CompetitorsAIM ImmunoTechNYSE:AIMPharmaCyte BiotechNASDAQ:PMCBEvaxion Biotech A/SNASDAQ:EVAXSQZ BiotechnologiesNYSE:SQZAptose BiosciencesNASDAQ:APTOView All CompetitorsInstitutional OwnershipAaron Wealth Advisors LLCBought 3,170 shares on 7/22/2024Ownership: 1.450%Virtu Financial LLCBought 16,374 shares on 5/20/2024Ownership: 1.213%View All Institutional Transactions CELZ Stock Analysis - Frequently Asked Questions How have CELZ shares performed this year? Creative Medical Technology's stock was trading at $4.61 on January 1st, 2024. Since then, CELZ shares have decreased by 21.3% and is now trading at $3.63. View the best growth stocks for 2024 here. How were Creative Medical Technology's earnings last quarter? Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) posted its earnings results on Friday, May, 10th. The company reported ($0.73) earnings per share for the quarter, topping the consensus estimate of ($1.15) by $0.42. When did Creative Medical Technology's stock split? Creative Medical Technology's stock reverse split before market open on Sunday, June 11th 2023. The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are Creative Medical Technology's major shareholders? Top institutional investors of Creative Medical Technology include Aaron Wealth Advisors LLC (1.45%). Insiders that own company stock include Timothy Warbington and Michael H Finger. View institutional ownership trends. How do I buy shares of Creative Medical Technology? Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CELZ) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.